Skip to main content
Log in

Connection between human leucocyte antigens D region and T helper cytokines in preeclampsia

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract.

Preeclampsia is a common and major cause of maternal and perinatal morbidity and mortality. Human leucocyte antigen (HLA) susceptibility and impaired adaptation of the T lymphocyte sub-population and a bi-directional effect of T helper cytokines on the outcome of pregnancy have been reported in patients with preeclampsia. The association between maternal HLA class II and T helper cytokines in women with preeclampsia was investigated in seventy-six preeclamptic women and normotensive controls using Terasaki microlymphocytotoxicity test. T helper cytokines interleukin (IL)-8, IL-6, IL-4, tumour necrosis factor (TNF)-α and interferon (IFN)-γ were estimated in the maternal blood and placenta by enzyme-linked immunosorbent assay (ELISA). Histopathological evaluation of the placenta was also carried out. HLA class II DR2, DR4, DR5, DRw8, DRw10, DRw11, DRw18, and DQw2 had significant relative risk ratios for preeclampsia, while DQw3 was more common in the controls. DR4-DRw11-DQw2 haplotype was more common in preeclamptic women with intrauterine growth restriction, low birth weight and placental weight, increased expression of T helper cytokines IL-8, TNF-α and IFN-γ and abnormal uteroplacental vasculature. These findings suggest that HLA class II DR4-DRw11 -DQw2 haplotypes may be associated with preeclampsia with intrauterine growth restriction through low placental weight from impaired placental development, as a result of increased expression of T helper 1 cytokines IL-8, TNF-α and IFN-γ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Biagini G, Pugnaloni A, Carboni V, Mazzanti L, Cester N, Romanini C, Toschi E, Castaldini C (1992) Placental villi–decidua interactions innormal and hypertensive pregnancies. A morphological quantitative study. Gynecol Obstet Invest 34:15–19

    Article  CAS  PubMed  Google Scholar 

  2. Kilpatrick D C, Liston W A, Gibson F, Livingstone J (1990) Association between susceptibility to preeclampsia within families and HLA DR. Lancet 335:660–661

  3. Kuhnert M, Strohmeier R, Stegm Yller M, Halberstad T (1998) Changes in lymphocyte subpopulation during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 76:147–151

    Article  CAS  PubMed  Google Scholar 

  4. Lin H, Mosmann TR, Guilbert L, Tantipopipat S, Wegmann TG (1993) Synthesis of T helper 2-type cytokine at the maternal–fetal interface. J Immunol 151:4562–4573

    Article  CAS  PubMed  Google Scholar 

  5. Liu, CL, Xu HY, Liu Y (1994) Serum level of soluble interleukin-2 receptor and T lymphocyte sub population in normal pregnancy. Chug Hua Ko Tsa Chih 29:518–520

    CAS  Google Scholar 

  6. Marinoni E, De Pita, Bresadola M, Ippoliti F, Dilorio R (1994) Cell-mediated immunity imbalanced in pregnancy, induced hypertension. Gynecol Obstet Invest 38:236–240

  7. Neefjes JJ, Ploegh HL (1992) Intracellular transport of MHC class II molecules. Immunol Today 13:179–189

    Article  CAS  PubMed  Google Scholar 

  8. Omu AE Al-Othman S, Al-Qattan F, Al-Falah FZ, Sherma P (1996) A comparative study of Obstetric outcome of patients with pregnancy induced hypertension: economic considerations. Acta Obstet Gynecol 75:443–448

    Article  CAS  Google Scholar 

  9. Omu AE, Al-Qattan F, Bukhadour N (1998) Human leukocyte antigens in pregnant women with preeclampsia associated with intrauterine growth retardation and in normal controls. Arch Gynecol Obstet 261:129–137

    Article  CAS  PubMed  Google Scholar 

  10. Omu AE, Al-Qattan F, Diejomaoh ME, Al-Yatama (1999) Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. Acta Obstet Gynecol Scand 78:675–680

  11. Opsjon S, Wathen N C, Tingulstads, Wiedswang G, Sundan A, Waage A, Anstgulen R (1995) Tumor necrosis factor, interleukin-1 and interleukin-6 in human pregnancy. Am J Obstet Gynecol 102:397–404

  12. Schneider K, Knutsen F, Tamsen L, Sjogerg O (1993) HLA sharing in preeclampsia. Gynecol Obstet Invest 37:87–90

    Article  Google Scholar 

  13. Sibai BM, Taslimi M, Abdella TN, Books TF, Spinnato JA, Anderson GD (1985) Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 87:32–37

    Google Scholar 

  14. Simon P, Fauchet R, Ang K S, Pilorge M, Calvez C, Le Fiblec B,Gam G, Laurent M et al (1988) Increase of the frequency of HLA- DR4 antigens in recurrent arterial hypertension of pregnancy. Arch Mal Coeur Vaiss 81:291–295

    PubMed  Google Scholar 

  15. Vander beeken YE, Duchteau J, Gregorie M et al (1991) Modulation of B cell stimulation. Immunol Invert 20:287–304

    Article  CAS  Google Scholar 

  16. Wegmann TG. Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine interactions in the maternal fetal relationship is a successful pregnancy a T helper 2 phenomenon. Immunol Today 14:353–356

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements.

The study was supported by Kuwait University Research Administration grant no. MO 0033.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander E. Omu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Omu, A.E., Al-Azemi, M.K., Al-Qattan, F. et al. Connection between human leucocyte antigens D region and T helper cytokines in preeclampsia. Arch Gynecol Obstet 269, 79–84 (2004). https://doi.org/10.1007/s00404-002-0436-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-002-0436-y

Keywords.

Navigation